CCM
STJ

Compton Capital Management’s St Jude Medical STJ Stock Holding History

Compton Capital Management’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,725
Closed -$619K – 151
2016
Q4 		$619K Hold
7,725
– – 0.32% 81
2016
Q3 		$616K Buy
7,725
+100
+1% +$8.07K 0.34% 73
2016
Q2 		$595K Buy
+7,625
New +$544K 0.33% 75

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Compton Capital Management's STJ Position: Q1 2017 in Review

Compton Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 7,725 shares — an estimated $619K sold.

Compton Capital Management first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $619K in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Compton Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Compton Capital Management sold 7,725 St Jude Medical shares in Q1 2017, an estimated $619K.
  • Compton Capital Management first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Compton Capital Management's St Jude Medical position peaked at $619K in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Compton Capital Management's 13F filing for Q1 2017, filed 9 May 2017.